Pfizer says its COVID-19 pill cuts disease’s worst risks by 89% : Coronavirus Updates : NPR
Coronavirus Updates : NPR
Pfizer says that its COVID-19 pill reduced the risk of hospitalization or death by 89%, in a clinical trial that tested the drug in adults with the disease who were also in high-risk health groups.
The oral medicine is called Paxlovid. Similar to Merck's new pill that was approved in the U.K. Thursday, Pfizer said its drug showed good results when administered within the first five days of the first COVID-19 symptoms.
Based on the strength of the trial's results, Pfizer says it will stop enrolling people into more clinical trials for the pill and will instead send the results it has so far to the U.S. Food and Drug Administration, to seek emergency use authorization.

